IVF with HSAs Act of 2024

Bill 118 hr 9141, also known as the IVF with HSAs Act of 2024, is a piece of legislation currently being considered by the US Congress. The bill aims to allow individuals to use funds from their Health Savings Accounts (HSAs) to cover the costs of in vitro fertilization (IVF) procedures.

Under current law, HSAs can only be used to pay for qualified medical expenses, such as doctor visits, prescription medications, and certain medical procedures. IVF, however, is not currently considered a qualified medical expense, meaning individuals cannot use their HSA funds to cover the costs of this fertility treatment.

The IVF with HSAs Act of 2024 seeks to change this by allowing individuals to use their HSA funds to pay for IVF procedures. This would provide individuals struggling with infertility the financial support they need to pursue IVF treatment, which can be costly and often not covered by insurance. Supporters of the bill argue that allowing HSA funds to be used for IVF will help make fertility treatment more accessible and affordable for individuals who may not be able to afford it otherwise. They believe that this change will help more people build the families they desire. Opponents of the bill, however, may argue that using HSA funds for IVF could lead to increased healthcare costs overall, as it may incentivize individuals to pursue expensive fertility treatments that may not always be successful. They may also raise concerns about the potential ethical implications of using HSA funds for IVF. Overall, the IVF with HSAs Act of 2024 is a proposed piece of legislation that aims to expand the allowable uses of HSA funds to cover the costs of IVF procedures. It is currently being debated in Congress, and its outcome will have implications for individuals seeking fertility treatment in the United States.